Philadelphia Chromosome‐positive Chronic Myelogenous Leukemia with Deleted Fusion of BCR and ABL Genes

Lignende værker

• Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells
  af: Okabe, Seiichi, et al.
  Udgivet: (2018)
• Combination therapy with copanlisib and ABL tyrosine kinase inhibitors against Philadelphia chromosome-positive resistant cells
  af: Okabe, Seiichi, et al.
  Udgivet: (2016)
• Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells
  af: Okabe, Seiichi, et al.
  Udgivet: (2013)
• Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
  af: Rubin, C M, et al.
  Udgivet: (1988)
• Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cells
  af: Okabe, Seiichi, et al.
  Udgivet: (2014)